Q4 2018 Iovance Biotherapeutics Inc Earnings Call Transcript
Good afternoon, and welcome to the Iovance Biotherapeutics Fourth Quarter and year-end 2018 Financial Results Conference Call. (Operator Instructions) Please be advised that the call is being recorded at the company's request. Now I'd like to turn the conference over to Tim Morris, Chief Financial Officer at Iovance. Sir, please go ahead.
Thank you, operator. Good afternoon, everyone and thanks for joining us today. With me on today's call is Maria Fardis, our President and CEO, and Debora Barton, our SVP of Clinical. This afternoon, we issued a press release that you can find on our website at iovance.com, which includes financial results for the fourth quarter and year ended December 31, 2018, and a corporate update.
Before I turn the call over to Maria, I'd like to remind everyone that statements made during this conference call will include forward-looking statements regarding Iovance's goals, business focus, business plans,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |